| 2024-03-13 | Delaet Ingrid | Chief Regulatory Officer | Sale+OE | 3,000 | $140.14 | $420,419.40 | -28.6% | → |
| 2024-03-11 | Delaet Ingrid | Chief Regulatory Officer | Sale+OE | 2,000 | $140.03 | $280,052.56 | -11.8% | → |
| 2024-03-11 | POPS RICHARD F | Director | Sale+OE | 1,800 | $140.04 | $252,078.03 | -3.0% | → |
| 2024-02-29 | Delaet Ingrid | Chief Regulatory Officer | Sale+OE | 6,817 | $135.34 | $922,631.73 | -18.5% | → |
| 2024-02-28 | BENEVICH ERIC | Chief Commercial Officer | Sale+OE | 75,000 | $134.69 | $10,101,607.50 | -48.0% | → |
| 2024-02-27 | Norwalk Leslie V | Director | Sale+OE | 8,000 | $135.67 | $1,085,388.00 | -100% | → |
| 2024-02-20 | POPS RICHARD F | Director | Sale+OE | 15,000 | $132.47 | $1,987,047.00 | -33.7% | → |
| 2024-02-13 | Lippoldt Darin | Chief Legal Officer | Sell | 1,098 | $132.99 | $146,028.40 | -2.7% | → |
| 2024-02-13 | ABERNETHY MATT | Chief Financial Officer | Sell | 1,352 | $132.85 | $179,611.58 | -4.1% | → |
| 2024-02-13 | Onyia Jude | Chief Scientific Officer | Sell | 1,432 | $132.94 | $190,371.08 | -9.8% | → |
| 2024-02-13 | Boyer David W. | Chief Corp. Affairs Officer | Sell | 1,811 | $133.07 | $240,995.73 | -14.5% | → |
| 2024-02-13 | ROBERTS EIRY | Chief Medical Officer | Sell | 1,114 | $132.96 | $148,121.78 | -4.5% | → |
| 2024-02-13 | Delaet Ingrid | Chief Regulatory Officer | Sell | 716 | $133.03 | $95,252.77 | -8.7% | → |
| 2024-02-13 | Gano Kyle | Chief Business Development Off | Sell | 1,352 | $132.89 | $179,673.63 | -1.0% | → |
| 2024-02-13 | BENEVICH ERIC | Chief Commercial Officer | Sell | 1,098 | $133.01 | $146,050.36 | -2.6% | → |
| 2024-02-13 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 2,832 | $133.02 | $376,700.46 | -0.5% | → |
| 2024-02-13 | Cooke Julie | Chief Human Resources Officer | Sell | 796 | $133.04 | $105,902.15 | -4.2% | → |
| 2024-02-08 | Cooke Julie | Chief Human Resources Officer | Sell | 2,544 | $138.61 | $352,612.24 | -3.5% | → |
| 2024-02-08 | Boyer David W. | Chief Corp. Affairs Officer | Sell | 1,784 | $137.09 | $244,563.90 | -8.0% | → |
| 2024-02-08 | ROBERTS EIRY | Chief Medical Officer | Sell | 2,101 | $138.49 | $290,968.09 | -4.5% | → |
| 2024-02-08 | ABERNETHY MATT | Chief Financial Officer | Sell | 2,260 | $138.73 | $313,529.61 | -3.6% | → |
| 2024-02-08 | Gano Kyle | Chief Business Development Off | Sell | 2,580 | $139.16 | $359,041.22 | -1.0% | → |
| 2024-02-08 | BENEVICH ERIC | Chief Commercial Officer | Sell | 2,260 | $138.68 | $313,418.67 | -2.8% | → |
| 2024-02-08 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 5,314 | $138.74 | $737,270.71 | -0.5% | → |
| 2024-02-08 | Lippoldt Darin | Chief Legal Officer | Sell | 1,952 | $138.47 | $270,284.02 | -2.5% | → |
| 2024-02-01 | Delaet Ingrid | Chief Regulatory Officer | Sell | 1,045 | $140.65 | $146,975.39 | -7.3% | → |
| 2024-01-31 | Gano Kyle | Chief Business Development Off | Sell | 1,541 | $140.70 | $216,812.54 | -1.2% | → |
| 2024-01-31 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 2,707 | $140.69 | $380,844.58 | -0.5% | → |
| 2024-01-31 | Lippoldt Darin | Chief Legal Officer | Sell | 1,250 | $140.65 | $175,809.75 | -3.3% | → |
| 2024-01-31 | Onyia Jude | Chief Scientific Officer | Sell | 126 | $141.94 | $17,884.44 | -1.1% | → |